Clinical Trial Update: Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Acular LS with Lotemax for preventing inflammation after cataract surgery and intraocular lens implantation; study status: comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• ACULAR LS (Ketorolac tromethamine)
• Lotemax (Loteprednol etabonate)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Cataract Extraction | Phase 4 | Status: COMPLETED